Viewing Study NCT06816966


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-27 @ 12:33 PM
Study NCT ID: NCT06816966
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-02-10
First Post: 2025-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Sponsor: Fujian Medical University Union Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small-cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radiation View
None split View
None hypofractionated radiotherapy View